BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23831917)

  • 1. Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.
    Ferreira SG; Teixeira FM; Garção P; Agostinho P; Ledent C; Cortes L; Mackie K; Köfalvi A
    Neurochem Int; 2012 Jul; 61(2):219-26. PubMed ID: 22609378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling.
    Stachowicz K
    Neurosci Biobehav Rev; 2023 Dec; 155():105439. PubMed ID: 37898448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV1 channels control synaptic plasticity in the developing superior colliculus.
    Maione S; Cristino L; Migliozzi AL; Georgiou AL; Starowicz K; Salt TE; Di Marzo V
    J Physiol; 2009 Jun; 587(Pt 11):2521-35. PubMed ID: 19406878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinin, Isolated from Heliopsis longipes, Induces an Antihypertensive Effect That Involves CB1 Cannabinoid Receptors and TRPA1 and TRPV1 Channel Activation.
    Luz-Martínez BA; Marrero-Morfa D; Luna-Vázquez FJ; Rojas-Molina A; Ibarra-Alvarado C
    Planta Med; 2024 May; 90(5):380-387. PubMed ID: 38219731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting corticostriatal transmission for the treatment of cannabinoid use disorder.
    Ferré S; Köfalvi A; Ciruela F; Justinova Z; Pistis M
    Trends Pharmacol Sci; 2023 Aug; 44(8):495-506. PubMed ID: 37331914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not So Vanilla: What Dermatologists Should Know About Vanilloid Receptors.
    Whiting C; Azim SA; Friedman A
    J Drugs Dermatol; 2023 Dec; 22(12):1237-1238. PubMed ID: 38051851
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular and Functional Study of Transient Receptor Potential Vanilloid 1-4 at the Rat and Human Blood-Brain Barrier Reveals Interspecies Differences.
    Luo H; Saubamea B; Chasseigneaux S; Cochois V; Smirnova M; Glacial F; Perrière N; Chaves C; Cisternino S; Declèves X
    Front Cell Dev Biol; 2020; 8():578514. PubMed ID: 33262985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Potential Targets for Therapeutic Intervention in Epilepsy.
    Zavala-Tecuapetla C; Cuellar-Herrera M; Luna-Munguia H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin.
    Pinheiro BS; Lemos C; Neutzling Kaufmann F; Marques JM; da Silva-Santos CS; Carvalho E; Mackie K; Rodrigues RJ; Cunha RA; Köfalvi A
    Brain Res Bull; 2016 Jun; 124():222-30. PubMed ID: 27208730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartment-specific modulation of GABAergic synaptic transmission by TRPV1 channels in the dentate gyrus.
    Chávez AE; Hernández VM; Rodenas-Ruano A; Chan CS; Castillo PE
    J Neurosci; 2014 Dec; 34(50):16621-9. PubMed ID: 25505315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.
    Sousa-Valente J; Andreou AP; Urban L; Nagy I
    Br J Pharmacol; 2014 May; 171(10):2508-27. PubMed ID: 24283624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain.
    Köles L; Garção P; Zádori ZS; Ferreira SG; Pinheiro BS; da Silva-Santos CS; Ledent C; Köfalvi A
    Brain Res Bull; 2013 Aug; 97():126-35. PubMed ID: 23831917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum.
    De Chiara V; Motta C; Rossi S; Studer V; Barbieri F; Lauro D; Bernardi G; Centonze D
    Neuroscience; 2013 Oct; 250():232-9. PubMed ID: 23856068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors.
    Marinelli S; Di Marzo V; Florenzano F; Fezza F; Viscomi MT; van der Stelt M; Bernardi G; Molinari M; Maccarrone M; Mercuri NB
    Neuropsychopharmacology; 2007 Feb; 32(2):298-308. PubMed ID: 16760924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
    Fawley JA; Hofmann ME; Andresen MC
    J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.
    Lowin T; Straub RH
    Arthritis Res Ther; 2015 Sep; 17(1):226. PubMed ID: 26343051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine-cannabinoid receptor interactions. Implications for striatal function.
    Ferré S; Lluís C; Justinova Z; Quiroz C; Orru M; Navarro G; Canela EI; Franco R; Goldberg SR
    Br J Pharmacol; 2010 Jun; 160(3):443-53. PubMed ID: 20590556
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.